本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

4D Molecular Therapeutics

3.63
+0.07001.97%
盤後3.630.00000.00%16:59 EDT
成交量:61.86萬
成交額:220.03萬
市值:1.68億
市盈率:-1.22
高:3.66
開:3.56
低:3.45
收:3.56
資料載入中...

公司資料

公司名字:
4D Molecular Therapeutics
交易所:
NASDAQ
成立時間:
2013
員工人數:
227
公司地址:
5858 Horton Street,Suite 455,Emeryville,California,United States
郵編:
94608
電話:
傳真:
- -
簡介:
4D Molecular Therapeutics, Inc.於2015年3月11日根據特拉華州法律成立。該公司是一家領先的臨床階段生物製藥公司,專註於通過針對特定疾病治療進行優化的專有定製載體釋放基因藥物的全部潛力。

董事

名稱
職位
David Kirn
Chief Executive Officer and Director
John F. Milligan
Executive Chairman
David Schaffer
Director and Chief Scientific Advisor
Charles Theuer
Director
Jacob Chacko
Director
Nancy Miller Rich
Director
Shawn Cline Tomasello
Director
Susannah Gray
Director
Tony Yao
Director
William Burkoth
Director

股東

名稱
職位
David Kirn
Chief Executive Officer and Director
Fred Kamal
Chief Operating Officer and Chief Technical Officer
August Moretti
Chief Financial Officer
David Schaffer
Director and Chief Scientific Advisor
Peter Francis
Chief Scientific Officer
Robert Fishman
Chief Medical Officer
Theresa Janke
Chief Strategy Officer